OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells
Una Glamočlija, Lejla Mahmutović, Esma Bilajac, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Una Glamočlija, Lejla Mahmutović, Esma Bilajac, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Showing 12 citing articles:
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 17
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 17
Metformin's Anticancer Odyssey: Revealing Multifaceted Mechanisms Across Diverse Neoplastic Terrains- A Critical Review
Rashmi Saxena Pal, Talha Jawaid, Md. Azizur Rahman, et al.
Biochimie (2025)
Open Access
Rashmi Saxena Pal, Talha Jawaid, Md. Azizur Rahman, et al.
Biochimie (2025)
Open Access
Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K /mTOR /HIF1α pathway and increasing oxidative stress in colon cancer cells
Wesam F. Farrash, Akhmed Aslam, Riyad A. Almaimani, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 831-848
Closed Access | Times Cited: 11
Wesam F. Farrash, Akhmed Aslam, Riyad A. Almaimani, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 831-848
Closed Access | Times Cited: 11
Research Progress on the Use of Metformin in Leukemia Treatment
Qian Wang, Xudong Wei
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 2, pp. 220-236
Open Access | Times Cited: 3
Qian Wang, Xudong Wei
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 2, pp. 220-236
Open Access | Times Cited: 3
The influence of Nigella sativa essential oil on proliferation, activation, and apoptosis of human T lymphocytes in vitro
Klaudia Ciesielska-Figlon, Agnieszka Daca, Adam Kokotkiewicz, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113349-113349
Closed Access | Times Cited: 15
Klaudia Ciesielska-Figlon, Agnieszka Daca, Adam Kokotkiewicz, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113349-113349
Closed Access | Times Cited: 15
Repurposing Metformin in hematologic tumor: State of art
Min Hu, Yan Chen, Tao Ma, et al.
Current Problems in Cancer (2023) Vol. 47, Iss. 4, pp. 100972-100972
Open Access | Times Cited: 7
Min Hu, Yan Chen, Tao Ma, et al.
Current Problems in Cancer (2023) Vol. 47, Iss. 4, pp. 100972-100972
Open Access | Times Cited: 7
Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
Esma Bilajac, Lejla Mahmutović, Una Glamočlija, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 58-58
Open Access | Times Cited: 9
Esma Bilajac, Lejla Mahmutović, Una Glamočlija, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 58-58
Open Access | Times Cited: 9
Metformin synergizes with gilteritinib in treating FLT3-mutated leukemia via targeting PLK1 signaling
Meiling Chen, Chao Shen, Yi‐Ping Phoebe Chen, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101645-101645
Open Access | Times Cited: 1
Meiling Chen, Chao Shen, Yi‐Ping Phoebe Chen, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101645-101645
Open Access | Times Cited: 1
Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia
Meher B. Gayatri, Rama Krishna Kancha, Dorababu Patchva, et al.
FEBS Journal (2023) Vol. 290, Iss. 18, pp. 4480-4495
Closed Access | Times Cited: 3
Meher B. Gayatri, Rama Krishna Kancha, Dorababu Patchva, et al.
FEBS Journal (2023) Vol. 290, Iss. 18, pp. 4480-4495
Closed Access | Times Cited: 3
Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells
Esma Bilajac, Una Glamočlija, Amar Osmanović, et al.
Croatica Chemica Acta (2023) Vol. 96, Iss. 1, pp. 59-68
Open Access | Times Cited: 2
Esma Bilajac, Una Glamočlija, Amar Osmanović, et al.
Croatica Chemica Acta (2023) Vol. 96, Iss. 1, pp. 59-68
Open Access | Times Cited: 2
Single and Combinatorial Effects of Metformin and Thymoquinone in Diffuse Large B Cell Lymphoma Cells
Una Glamočlija, Lejla Mahmutović, Esma Bilajac, et al.
Chemistry & Biodiversity (2024)
Open Access
Una Glamočlija, Lejla Mahmutović, Esma Bilajac, et al.
Chemistry & Biodiversity (2024)
Open Access
SYNTHESIS, IN SILICO STUDY AND ANTITUMOR ACTIVITY OF COUMARIN COMPOUNDS IN LYMPHOMA CELLS
Esma Bilajac
FARMACIA (2023) Vol. 71, Iss. 6, pp. 1263-1273
Open Access | Times Cited: 1
Esma Bilajac
FARMACIA (2023) Vol. 71, Iss. 6, pp. 1263-1273
Open Access | Times Cited: 1
Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access
